Given the recent surge in interest in generative AI, it’s no wonder that consultancies like McKinsey are making hay of the situation. The consultancy recently argued that “Rewired pharma companies will win in the digital age.” In a separate feature, it noted that generative AI could boost biopharma R&D productivity by billions, as we reported…

Unveiling Sanofi’s AI-powered pharma strategy, the French pharma giant announced its plans to tap AI for insights across the company. With “plai,” an internal app, AI could provide real-time data supporting decision-making. Sanofi’s goal, as CEO Paul Hudson stated in a news release, is to become the first pharma company powered by AI at scale,…